Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

17
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
17

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Executive summary of the European consensus report on the diagnosis and treatment of monoclonal gammopathy of renal significance.

Clinical kidney journal·2026
Same author

Impact of an Intradialytic Nonimmersive Virtual Reality Platform on Functional Capacity: The GoodRENal Pilot Feasibility Study.

Kidney medicine·2026
Same author

A nephrology perspective on the clinical impact and management of delayed high-dose methotrexate elimination.

Expert review of anticancer therapy·2026
Same author

Ten tips to control blood pressure in haemodialysis patients.

Clinical kidney journal·2026
Same author

Single-cell insights into maladaptive endothelial plasticity and therapeutic targets in diabetic vascular complications.

Cardiovascular diabetology·2026
Same author

Shall we go for a walk? A cross-sectional study comparing the 6 min walk test and cardiopulmonary exercise test for assessing cardiorespiratory fitness in de novo kidney transplant recipients.

BMJ open sport & exercise medicine·2026

Related Experiment Video

Updated: Aug 11, 2025

Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue
05:46

Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue

Published on: June 9, 2020

4.0K

Deconvolution of Focal Segmental Glomerulosclerosis Pathophysiology Using Transcriptomics Techniques.

Dries Deleersnijder1,2, Amaryllis H Van Craenenbroeck2,3, Ben Sprangers1,2

  • 1Department of Microbiology, Immunology and Transplantation, Laboratory of Molecular Immunology, Rega Institute, KU Leuven, Leuven, Belgium.

Glomerular Diseases
|February 8, 2023
PubMed
Summary
This summary is machine-generated.

New transcriptomics techniques offer hope for identifying biomarkers in focal segmental glomerulosclerosis (FSGS). These advancements can improve diagnosis, prognosis, and treatment strategies for FSGS patients.

Keywords:
BiomarkerFocal segmental glomerulosclerosisSingle-cell transcriptomicsTranscriptomics

More Related Videos

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
06:39

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation

Published on: August 19, 2020

5.7K
Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

6.9K

Related Experiment Videos

Last Updated: Aug 11, 2025

Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue
05:46

Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue

Published on: June 9, 2020

4.0K
Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
06:39

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation

Published on: August 19, 2020

5.7K
Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

6.9K

Area of Science:

  • Nephrology
  • Genomics
  • Biomarker Discovery

Background:

  • Focal segmental glomerulosclerosis (FSGS) is a complex kidney disease with diverse causes and challenging clinical management.
  • Current diagnostic and prognostic tools for FSGS are limited, hindering personalized treatment approaches.
  • There is a critical need for reliable biomarkers to differentiate FSGS subtypes and guide therapy.

Purpose of the Study:

  • To explore the potential of transcriptomics for identifying novel biomarkers in FSGS.
  • To investigate how gene expression profiling can enhance the understanding of FSGS pathophysiology.
  • To pave the way for improved clinical applications of transcriptomics in FSGS management.

Main Methods:

  • Utilizing advanced transcriptomics techniques, including RNA-sequencing and single-cell transcriptomics.
  • Integrating gene expression data with functional in vitro and in vivo experimental studies.
  • Correlating gene expression profiles with clinical outcomes in large patient cohorts.

Main Results:

  • Transcriptomics enables high-throughput gene expression profiling in FSGS patients.
  • Integration of data provides mechanistic insights into candidate genes.
  • Biomarker discovery through gene expression profiling is feasible for clinical application.

Conclusions:

  • New transcriptomics techniques are revolutionizing kidney research for FSGS.
  • These methods facilitate the discovery of clinically applicable biomarkers for FSGS.
  • Advancements in transcriptomics hold significant promise for improving patient outcomes in FSGS.